10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $434,445 | -27.4% | 10,532 | -1.7% | 0.01% | -25.0% |
| Q2 2023 | $598,270 | -1.2% | 10,714 | -1.3% | 0.01% | -7.7% |
| Q1 2023 | $605,824 | -0.7% | 10,859 | -35.1% | 0.01% | -7.1% |
| Q4 2022 | $610,006 | +7.0% | 16,740 | -16.4% | 0.01% | +7.7% |
| Q3 2022 | $570,000 | +25.3% | 20,020 | +99.3% | 0.01% | +30.0% |
| Q2 2022 | $455,000 | -23.4% | 10,047 | +28.8% | 0.01% | -9.1% |
| Q1 2022 | $594,000 | – | 7,803 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |